(MENAFN- GlobeNewsWire - Nasdaq) Key sectors in the white biotechnology market include biofuels, biochemicals, industrial enzymes, and biomaterials, with new fields like bioremediation emerging. Advances in synthetic biology and digital tools such as machine learning are accelerating product development and market entry, driving growth from niche to large-scale industrial applications. The market is in a growth phase, buoyed by rising demand for renewable resources but challenged by high initial investment costs. Notable players include Novozymes, DuPont, BASF, and Evonik. North America is a key region, driven by government initiatives for renewable resources.

Dublin, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The "White Biotechnology Market - A Global and Regional Analysis: Focus on Application, Product, and Country Analysis - Analysis and Forecast, 2025-2034" report has been added to ResearchAndMarkets.com's offering.
White biotechnology also known as industrial biotechnology leverages living cells, enzymes and fermentation processes to produce bio-based chemicals, materials and energy carriers. Core application areas include biofuels (e.g., advanced biodiesel and bioethanol), biochemicals (organic acids, solvents), industrial enzymes (for detergents, textiles, food processing), biomaterials (biopolymers, bioplastics) and emerging fields such as bioremediation and renewable feedstock valorization.

Technological advances in synthetic biology, metabolic engineering and protein engineering are enabling more efficient strain development, higher yields and reduced process costs. Concurrently, digital tools - machine learning for bioprocess optimization, high-throughput screening and scalable continuous-flow fermentation - are accelerating time-to-market for new bioproducts. This convergence of biology and digitalization is driving white biotechnology market's transformation from niche specialty applications toward large-scale industrial adoption.

The white biotechnology market is firmly in its growth phase, characterized by robust R&D investment, rapid technology commercialization and an expanding base of both established chemical-industry incumbents and agile biotech startups. Market concentration remains moderate, with innovation dispersed across diverse segments - from enzyme producers like Novozymes and DuPont to bio-based materials pioneers - indicating ample room for new entrants.

As process efficiencies improve and regulatory frameworks for bio-based products mature, the industry is poised to transition toward consolidation and maturation over the next decade, with large strategic partnerships and mergers likely to shape the competitive landscape.

White Biotechnology Market Key Players and Competition Synopsis
The white biotechnology market sector is characterized by a diverse competitive landscape dominated by established chemical and life-sciences firms alongside a wave of specialized biotech innovators.

Leading companies - such as Novozymes, DuPont de Nemours, BASF, Evonik Industries AG - leverage extensive R&D capabilities and global production networks to supply industrial enzymes, bio-based polymers and specialty biochemicals at scale.

At the same time, agile pure-play biotechnology companies - Amyris Inc., Genomatica Inc., Codexis Inc. and Ginkgo Bioworks - are differentiating themselves through advanced metabolic engineering, proprietary strain-development platforms and digital bioprocess optimization tools that accelerate time-to-market and reduce unit costs.

Mid-tier players including Archer Daniels Midland, Cargill Incorporated, Corbion N.V. and Lonza Group Ltd. compete on feedstock integration and circular-economy solutions, while an active M&A environment and strategic partnerships - linking chemical giants with biotech startups - continue to reshape market share, drive consolidation and foster next-generation technology transfer.
Some prominent names established in the white biotechnology market include:

• Medtronic
• Novozymes
• BASF
• DuPont
• Cargill, Inc.
• Royal DSM N.V.
• Archer Daniels Midland Company
• BioAmber Inc.
• Lesaffre
• Corbion N.V.
• Evonik Industries AG
• Genomatica, Inc
• Ginkgo Bioworks
• Amyris Inc.
• TerraVia Holdings, Inc

Key Attributes:

Report Attribute	Details
No. of Pages	120
Forecast Period	2025 - 2034
Estimated Market Value (USD) in 2025	$337.56 Billion
Forecasted Market Value (USD) by 2034	$672.92 Billion
Compound Annual Growth Rate	7.9%
Regions Covered	Global

Key Topics Covered:
1. Markets: Industry Outlook
1.1 Trends: Current and Future Impact Assessment
1.2 Stakeholder Analysis
1.3 Market Dynamics Overview
1.4 Investment Landscape and R&D Trends
1.5 Future Outlook and Market Roadmap
2. White Biotechnology Market (by Application)
2.1 Application Segmentation
2.2 Application Summary
2.3 White Biotechnology Market (by Application)
2.3.1 Bioenergy
2.3.2 Food and Feed Additives
2.3.3 Pharmaceutical Ingredients
2.3.4 Personal Care and Household Products
2.3.5 Others
3. White Biotechnology Market (by Product)
3.1 Product Segmentation
3.2 Product Summary
3.3 White Biotechnology Market (by Product Type)
3.3.1 Biochemical
3.3.2 Biofuel
3.3.3 Biomaterial
3.3.4 Bioproduct
4. White Biotechnology Market (by Region)
4.1 White Biotechnology Market (by Region)
4.2 North America
4.3 Europe
4.4 Asia-Pacific
4.5 Rest-of-the-World
5. Markets - Competitive Benchmarking & Company Profiles
5.1 Next Frontiers
5.2 Geographic Assessment
5.3 Company Profiles

• Medtronic
• Novozymes
• BASF SE
• DuPont
• Cargill, Inc.
• Royal DSM N.V.
• Archer Daniles Midland Company
• BioAmber Inc.
• Lesaffre
• Corbion N.V.
• Evonik Industries AG
• Genomatica, Inc
• Ginkgo Bioworks
• Amyris Inc.
• TerraVia Holdings, Inc

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Global White Biotechnology Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN04082025004107003653ID1109880662